Alphavax Human Vaccines Inc
AlphaVax Human Vaccines Inc., based in Durham, NC, is a privately-held clinical-stage biopharmaceutical company specializing in the development of innovative vaccines utilizing its proprietary RNA particle alphavaccine vector platform technology. The company focuses on anti-infective and anti-cancer vaccines, aiming to redefine their roles in medicine through a strategic approach that includes commercial partnerships for specific disease applications.
With a portfolio of seven vaccine candidates targeting infectious diseases and cancer immunotherapy, AlphaVax has conducted multiple Phase 1 clinical trials. Its research highlights include encouraging results in cancer treatments, such as enhanced survival in patients with Stage IV colon cancer, showcasing the potential of its alphavaccine technology to engage the immune system effectively.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.